コンテンツへスキップ
Merck
  • Cutaneous necrobiotic xanthogranuloma (NXG)--successfully treated with low dose chlorambucil.

Cutaneous necrobiotic xanthogranuloma (NXG)--successfully treated with low dose chlorambucil.

European journal of dermatology : EJD (2001-08-30)
S Machado, R Alves, M Lima, I Leal, A Massa
要旨

We report a case of necrobiotic xanthogranuloma in a 51 year-old white male patient presenting with a 6-year history of multiple indurated violaceous nodules and plaques involving the eyelids, trunk and extremities. He had an associated paraproteinemia (Ig G lambda), elevated sedimentation rate, cryoglobulinemia and hypocomplementemia. No extracutaneous involvement was detected. He was successfully treated with chlorambucil (2 mg/d for 7 months), leading to disappearance of all skin lesions.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
クロランブシル
カタログ番号
容量
在庫状況
単価
数量
クロランブシル, European Pharmacopoeia (EP) Reference Standard
カタログ番号
容量
在庫状況
単価
数量
システム適合性用クロラムブシル, European Pharmacopoeia (EP) Reference Standard
カタログ番号
容量
在庫状況
単価
数量